Clinical Trials Browser

Phase 1/2 × Lymphoproliferative Disorders × 90 days × Clear all

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

Clinical Trials

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL